 Eileen Chang
Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 6 | 2024 | 550 | 1.810 |
Why?
| | Fetus | 15 | 2024 | 770 | 1.790 |
Why?
| | Ketamine | 5 | 2018 | 85 | 1.550 |
Why?
| | Placental Insufficiency | 4 | 2021 | 112 | 1.400 |
Why?
| | Fetal Hypoxia | 6 | 2018 | 54 | 1.380 |
Why?
| | Sheep | 21 | 2024 | 838 | 1.360 |
Why?
| | Fetal Development | 3 | 2024 | 288 | 0.930 |
Why?
| | Muscle, Skeletal | 6 | 2022 | 1613 | 0.890 |
Why?
| | Fetal Heart | 1 | 2024 | 55 | 0.860 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 94 | 0.860 |
Why?
| | Muscle Development | 2 | 2021 | 103 | 0.800 |
Why?
| | Insulin-Like Growth Factor I | 5 | 2024 | 307 | 0.760 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.760 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 187 | 0.720 |
Why?
| | Amino Acids | 3 | 2022 | 486 | 0.690 |
Why?
| | Insulin | 4 | 2024 | 2325 | 0.620 |
Why?
| | Pregnancy | 16 | 2024 | 6391 | 0.590 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2018 | 100 | 0.520 |
Why?
| | Hypoxia, Brain | 1 | 2016 | 8 | 0.520 |
Why?
| | Cerebral Cortex | 2 | 2018 | 436 | 0.510 |
Why?
| | Lower Extremity | 1 | 2019 | 404 | 0.490 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2016 | 133 | 0.480 |
Why?
| | Anesthetics, Dissociative | 1 | 2015 | 26 | 0.470 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 122 | 0.470 |
Why?
| | Hydrocortisone | 2 | 2016 | 306 | 0.430 |
Why?
| | Citrate (si)-Synthase | 2 | 2024 | 57 | 0.410 |
Why?
| | Hypoxia | 5 | 2020 | 1084 | 0.410 |
Why?
| | Inflammation Mediators | 1 | 2016 | 505 | 0.410 |
Why?
| | Hypoglycemic Agents | 1 | 2021 | 1219 | 0.410 |
Why?
| | Animals | 28 | 2024 | 35309 | 0.390 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 480 | 0.390 |
Why?
| | Hypothalamus | 3 | 2016 | 149 | 0.320 |
Why?
| | Kidney | 1 | 2015 | 1385 | 0.290 |
Why?
| | Pregnancy, Animal | 2 | 2019 | 53 | 0.290 |
Why?
| | Umbilical Cord | 2 | 2018 | 83 | 0.270 |
Why?
| | Female | 23 | 2024 | 68556 | 0.250 |
Why?
| | Gestational Age | 4 | 2021 | 874 | 0.250 |
Why?
| | Oxidative Phosphorylation | 2 | 2024 | 187 | 0.250 |
Why?
| | Matrix Metalloproteinases | 3 | 2010 | 90 | 0.240 |
Why?
| | Infusions, Intravenous | 2 | 2024 | 399 | 0.230 |
Why?
| | Cell Respiration | 1 | 2024 | 98 | 0.220 |
Why?
| | Islets of Langerhans | 2 | 2021 | 789 | 0.210 |
Why?
| | Ventricular Remodeling | 3 | 2010 | 255 | 0.210 |
Why?
| | Drug Administration Schedule | 2 | 2021 | 768 | 0.200 |
Why?
| | Fetal Blood | 3 | 2021 | 317 | 0.190 |
Why?
| | Transcriptome | 3 | 2018 | 874 | 0.190 |
Why?
| | Muscle Proteins | 2 | 2022 | 220 | 0.190 |
Why?
| | Lipid Metabolism | 1 | 2024 | 497 | 0.180 |
Why?
| | Placenta | 4 | 2021 | 723 | 0.180 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 77 | 0.170 |
Why?
| | Glucose | 2 | 2024 | 1001 | 0.160 |
Why?
| | Hindlimb | 1 | 2019 | 122 | 0.160 |
Why?
| | Alanine | 1 | 2019 | 142 | 0.150 |
Why?
| | Sheep, Domestic | 2 | 2016 | 34 | 0.150 |
Why?
| | Coronary Vessels | 1 | 2020 | 239 | 0.150 |
Why?
| | Staphylococcus | 1 | 2017 | 74 | 0.140 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2017 | 71 | 0.140 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 756 | 0.140 |
Why?
| | Ventricular Function, Left | 2 | 2010 | 527 | 0.130 |
Why?
| | Temperature | 1 | 2019 | 634 | 0.130 |
Why?
| | Selection, Genetic | 2 | 2012 | 249 | 0.130 |
Why?
| | Triclosan | 1 | 2016 | 9 | 0.130 |
Why?
| | Gene Expression Profiling | 4 | 2016 | 1688 | 0.130 |
Why?
| | Anti-Infective Agents, Local | 1 | 2016 | 42 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 499 | 0.130 |
Why?
| | Endocrine Disruptors | 1 | 2016 | 40 | 0.120 |
Why?
| | Systems Biology | 1 | 2016 | 59 | 0.120 |
Why?
| | Mitochondria | 1 | 2021 | 877 | 0.120 |
Why?
| | Pituitary Gland | 1 | 2016 | 148 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2021 | 1266 | 0.120 |
Why?
| | Ischemia | 1 | 2018 | 406 | 0.120 |
Why?
| | Analgesics | 1 | 2016 | 189 | 0.120 |
Why?
| | Chemokines | 1 | 2015 | 226 | 0.110 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 211 | 0.110 |
Why?
| | Brachiocephalic Trunk | 1 | 2014 | 11 | 0.110 |
Why?
| | Saccharomyces cerevisiae | 2 | 2012 | 530 | 0.110 |
Why?
| | RNA, Messenger | 3 | 2016 | 2703 | 0.110 |
Why?
| | Interleukins | 1 | 2015 | 241 | 0.110 |
Why?
| | Disease Models, Animal | 5 | 2016 | 4057 | 0.110 |
Why?
| | Endocrine System | 1 | 2013 | 20 | 0.100 |
Why?
| | Blood Pressure | 3 | 2016 | 1736 | 0.100 |
Why?
| | Myosin Light Chains | 1 | 2012 | 27 | 0.100 |
Why?
| | Cardiac Myosins | 1 | 2012 | 30 | 0.100 |
Why?
| | Two-Hybrid System Techniques | 1 | 2012 | 56 | 0.100 |
Why?
| | Molecular Biology | 1 | 2012 | 56 | 0.100 |
Why?
| | Immune System | 1 | 2013 | 175 | 0.090 |
Why?
| | Transcription Factors | 2 | 2014 | 1647 | 0.090 |
Why?
| | Cardiomegaly | 1 | 2012 | 172 | 0.090 |
Why?
| | Hemodynamics | 1 | 2016 | 1090 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2012 | 335 | 0.090 |
Why?
| | Gene Expression | 1 | 2016 | 1466 | 0.090 |
Why?
| | Estradiol | 1 | 2014 | 494 | 0.090 |
Why?
| | Apoptosis | 1 | 2019 | 2499 | 0.090 |
Why?
| | Homeodomain Proteins | 1 | 2014 | 495 | 0.090 |
Why?
| | Heart Conduction System | 1 | 2010 | 95 | 0.080 |
Why?
| | Electric Stimulation Therapy | 1 | 2010 | 77 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 414 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2016 | 2537 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 513 | 0.080 |
Why?
| | Up-Regulation | 4 | 2014 | 839 | 0.080 |
Why?
| | Basigin | 1 | 2008 | 25 | 0.070 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2010 | 127 | 0.070 |
Why?
| | Fibroblasts | 2 | 2010 | 948 | 0.070 |
Why?
| | Genomics | 1 | 2013 | 717 | 0.070 |
Why?
| | Brain | 2 | 2017 | 2669 | 0.070 |
Why?
| | Time Factors | 2 | 2016 | 6543 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 317 | 0.070 |
Why?
| | Aorta, Thoracic | 1 | 2010 | 262 | 0.070 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 757 | 0.070 |
Why?
| | Oxygen | 2 | 2021 | 915 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2012 | 383 | 0.060 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2008 | 385 | 0.060 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2010 | 625 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2737 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2016 | 328 | 0.050 |
Why?
| | Genetic Complementation Test | 1 | 2003 | 63 | 0.050 |
Why?
| | Myocardium | 1 | 2008 | 978 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2010 | 898 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2018 | 820 | 0.050 |
Why?
| | Myocardial Infarction | 1 | 2010 | 1021 | 0.050 |
Why?
| | Energy Metabolism | 2 | 2021 | 873 | 0.050 |
Why?
| | Mice, Transgenic | 3 | 2014 | 2117 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 108 | 0.050 |
Why?
| | Blood Glucose | 2 | 2024 | 2097 | 0.050 |
Why?
| | Male | 9 | 2021 | 63517 | 0.050 |
Why?
| | Ventricular Pressure | 2 | 2012 | 44 | 0.050 |
Why?
| | Infusion Pumps | 1 | 2021 | 31 | 0.050 |
Why?
| | Down-Regulation | 2 | 2014 | 636 | 0.050 |
Why?
| | Placental Circulation | 1 | 2021 | 65 | 0.050 |
Why?
| | Placentation | 1 | 2021 | 44 | 0.040 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 62 | 0.040 |
Why?
| | Fetal Weight | 1 | 2021 | 56 | 0.040 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 70 | 0.040 |
Why?
| | Organ Size | 1 | 2021 | 446 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2021 | 158 | 0.040 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2010 | 54 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2135 | 0.040 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2018 | 25 | 0.040 |
Why?
| | Aging | 1 | 2008 | 1774 | 0.040 |
Why?
| | Swine | 2 | 2010 | 760 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 5439 | 0.040 |
Why?
| | Heart Ventricles | 2 | 2014 | 781 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2010 | 2342 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2018 | 321 | 0.030 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 308 | 0.030 |
Why?
| | Arteries | 1 | 2018 | 265 | 0.030 |
Why?
| | Echocardiography | 2 | 2010 | 629 | 0.030 |
Why?
| | Stroke Volume | 2 | 2010 | 592 | 0.030 |
Why?
| | Heart Rate | 2 | 2010 | 802 | 0.030 |
Why?
| | Microglia | 1 | 2017 | 232 | 0.030 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 161 | 0.030 |
Why?
| | Homeobox Protein Nkx-2.5 | 1 | 2014 | 4 | 0.030 |
Why?
| | Mice | 4 | 2014 | 16915 | 0.030 |
Why?
| | Reproduction | 1 | 2016 | 197 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 53 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2016 | 259 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2013 | 3080 | 0.030 |
Why?
| | Neuropeptides | 1 | 2014 | 71 | 0.030 |
Why?
| | Phenotype | 2 | 2014 | 3074 | 0.030 |
Why?
| | Disease Progression | 2 | 2012 | 2630 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 280 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 272 | 0.030 |
Why?
| | Gene Ontology | 1 | 2013 | 49 | 0.030 |
Why?
| | Cell Cycle | 1 | 2016 | 589 | 0.030 |
Why?
| | Models, Genetic | 1 | 2016 | 593 | 0.030 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2012 | 20 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 2013 | 77 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 87 | 0.020 |
Why?
| | Ubiquitin | 1 | 2012 | 64 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 317 | 0.020 |
Why?
| | Lymphocytes | 1 | 2014 | 378 | 0.020 |
Why?
| | Culture Media | 1 | 2012 | 160 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 148 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 841 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2014 | 426 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 321 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2016 | 622 | 0.020 |
Why?
| | Calcium Chloride | 1 | 2010 | 12 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2056 | 0.020 |
Why?
| | Thoracotomy | 1 | 2010 | 74 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2010 | 149 | 0.020 |
Why?
| | Diastole | 1 | 2010 | 148 | 0.020 |
Why?
| | Aorta | 1 | 2012 | 408 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2010 | 119 | 0.020 |
Why?
| | Systole | 1 | 2010 | 191 | 0.020 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2010 | 85 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2835 | 0.020 |
Why?
| | Angiotensin II | 1 | 2010 | 95 | 0.020 |
Why?
| | Macrophages | 1 | 2017 | 1484 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2014 | 616 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2010 | 110 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 143 | 0.020 |
Why?
| | Matrix Metalloproteinase 14 | 1 | 2008 | 2 | 0.020 |
Why?
| | Tachycardia, Ventricular | 1 | 2010 | 167 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2010 | 179 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 812 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1710 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 947 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 455 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 2871 | 0.020 |
Why?
| | Electrocardiography | 1 | 2010 | 608 | 0.020 |
Why?
| | Recovery of Function | 1 | 2010 | 641 | 0.020 |
Why?
| | Collagen | 1 | 2008 | 433 | 0.020 |
Why?
| | Fibrosis | 1 | 2008 | 520 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1835 | 0.010 |
Why?
| | Humans | 5 | 2021 | 129271 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1691 | 0.010 |
Why?
| | Tocopherols | 1 | 2003 | 25 | 0.010 |
Why?
| | Retinoid X Receptors | 1 | 2003 | 41 | 0.010 |
Why?
| | Receptors, Retinoic Acid | 1 | 2003 | 51 | 0.010 |
Why?
| | Receptors, Steroid | 1 | 2003 | 50 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2003 | 361 | 0.010 |
Why?
| | Tretinoin | 1 | 2003 | 130 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4077 | 0.010 |
Why?
| | Paclitaxel | 1 | 2003 | 217 | 0.010 |
Why?
| | Molecular Structure | 1 | 2003 | 481 | 0.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 217 | 0.010 |
Why?
| | Ligands | 1 | 2003 | 621 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3140 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2003 | 648 | 0.010 |
Why?
| | Antioxidants | 1 | 2003 | 558 | 0.010 |
Why?
| | Protein Binding | 1 | 2003 | 2120 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1446 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 4926 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2003 | 2054 | 0.010 |
Why?
|
|
Chang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|